Moser, Kara A <br/><br/>
Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential.  [electronic resource] 

 -  Genome medicine  01 2020 
 - 6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1756-994X 
<br/><br/><label>Standard No.: </label>10.1186/s13073-019-0708-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CD8-Positive T-Lymphocytes--immunology<br/>Clinical Trials as Topic--statistics & numerical data<br/>Genome, Protozoan<br/>Humans<br/>Immunogenicity, Vaccine<br/>Malaria Vaccines--genetics<br/>Plasmodium falciparum--genetics<br/>Polymorphism, Genetic